Status: Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.
Participants needed: 98
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Schrödinger, Inc.Updated: Feb 13, 2026Locations: 36
Eligibility criteria
Subject must have a history of histologically or cytologically confirmed mature... [+3]
The subject is in need of immediate cytoreductive therapy (unless the patient ha... [+4]